1. Home
  2. DIOD vs IBRX Comparison

DIOD vs IBRX Comparison

Compare DIOD & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DIOD
  • IBRX
  • Stock Information
  • Founded
  • DIOD 1959
  • IBRX 2014
  • Country
  • DIOD United States
  • IBRX United States
  • Employees
  • DIOD N/A
  • IBRX N/A
  • Industry
  • DIOD Semiconductors
  • IBRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DIOD Technology
  • IBRX Health Care
  • Exchange
  • DIOD Nasdaq
  • IBRX Nasdaq
  • Market Cap
  • DIOD 2.2B
  • IBRX 2.4B
  • IPO Year
  • DIOD N/A
  • IBRX N/A
  • Fundamental
  • Price
  • DIOD $51.00
  • IBRX $2.87
  • Analyst Decision
  • DIOD Buy
  • IBRX Strong Buy
  • Analyst Count
  • DIOD 2
  • IBRX 5
  • Target Price
  • DIOD $57.50
  • IBRX $11.40
  • AVG Volume (30 Days)
  • DIOD 398.4K
  • IBRX 10.1M
  • Earning Date
  • DIOD 08-07-2025
  • IBRX 08-11-2025
  • Dividend Yield
  • DIOD N/A
  • IBRX N/A
  • EPS Growth
  • DIOD N/A
  • IBRX N/A
  • EPS
  • DIOD 0.55
  • IBRX N/A
  • Revenue
  • DIOD $1,341,261,000.00
  • IBRX $31,222,000.00
  • Revenue This Year
  • DIOD $10.90
  • IBRX $567.98
  • Revenue Next Year
  • DIOD $7.36
  • IBRX $160.56
  • P/E Ratio
  • DIOD $92.22
  • IBRX N/A
  • Revenue Growth
  • DIOD N/A
  • IBRX 10238.41
  • 52 Week Low
  • DIOD $32.93
  • IBRX $1.83
  • 52 Week High
  • DIOD $86.74
  • IBRX $7.63
  • Technical
  • Relative Strength Index (RSI)
  • DIOD 62.41
  • IBRX 49.40
  • Support Level
  • DIOD $49.63
  • IBRX $2.77
  • Resistance Level
  • DIOD $52.42
  • IBRX $3.24
  • Average True Range (ATR)
  • DIOD 1.41
  • IBRX 0.23
  • MACD
  • DIOD -0.00
  • IBRX -0.03
  • Stochastic Oscillator
  • DIOD 83.43
  • IBRX 19.74

About DIOD Diodes Incorporated

Diodes Inc is a manufacturer and supplier of high-quality application-specific products within the broad discrete, logic, analog, and mixed-signal semiconductor markets. It serves the customer electronics, computing, communications, industrial, and automotive markets. The Company's products include diodes; rectifiers; transistors; MOSFETs; GPP bridges; GPP rectifiers; protection devices; function-specific arrays; single gate logic; amplifiers and comparators; Hall-effect and temperature sensors; and power management devices, including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators, voltage references along with special-function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

Share on Social Networks: